Atlas Venture Files Intent to Sell $3.5M in Dyne Therapeutics Stock, Continuing Recent Distribution

summarizeSummary

Atlas Venture, a major shareholder, plans to sell $3.52 million in Dyne Therapeutics stock, extending a recent trend of significant share dispositions totaling over $62 million in the last 90 days.

check_boxKey Events · Ownership and Investor Activity · DYN

• Intent to Sell Shares

  Atlas Venture Fund XI, LP, a major shareholder, filed a Form 144 to sell 153,966 shares of common stock, valued at approximately $3.52 million.

• Continuation of Share Distribution

  This proposed sale adds to a recent trend of significant share dispositions by Atlas Venture, which has sold over $62 million worth of Dyne Therapeutics stock in the past 90 days.

• Institutional Shareholder Activity

  The shares were acquired via private placement in July 2020, indicating a long-term holding now being partially liquidated.

auto_awesomeAnalysis · DYN · Life Sciences

Atlas Venture, a significant institutional shareholder, has filed a Form 144 indicating its intent to sell an additional $3.52 million worth of Dyne Therapeutics common stock. This proposed sale continues a pattern of substantial share dispositions by Atlas Venture, which has sold over $62 million in shares over the past 90 days. While the current filing's value is modest relative to the company's market cap, the ongoing sales by a major investor could create an overhang on the stock.